Crossmark

DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major depression disorders: a converging model for the therapeutic effects of psychedelic compounds in the treatment of psychiatric illness

Crossref DOI link: https://doi.org/10.1038/s41380-023-02235-4

Published Online: 2023-09-07

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Flynn, L. Taylor

Gao, Wen-Jun https://orcid.org/0000-0002-8585-3082
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R21MH121836, R21MH129989, R01MH131053)

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health

U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
License Information

Text and Data Mining valid from 2023-09-07

Version of Record valid from 2023-09-07
More Information

Article History

Received: 20 February 2023

Revised: 17 August 2023

Accepted: 22 August 2023

First Online: 7 September 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below